|
|
|
Insider
Information: |
Rosenbaum David P. |
Relationship: |
Chief Development Offi... |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
376,479 |
|
Indirect Shares
|
236,094 |
|
|
Direct
Value |
$2,300,287 |
|
|
Indirect Value
|
$1,442,534 |
|
|
Total
Shares |
612,573 |
|
|
Total
Value |
$3,742,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
36
|
Stock
price went up :
|
1
|
23
|
Stock
price went down : |
0
|
13
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.8
|
Percentage
Gain/Loss : |
276.6%
|
2,864.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Ardelyx Inc |
ARDX |
Chief Development Offi... |
2024-06-03 |
376,479 |
2024-06-03 |
236,094 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2024-01-08 |
4 |
AS |
$6.64 |
$199,200 |
D/D |
(30,000) |
286,596 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2020-09-15 |
4 |
S |
$5.52 |
$191,301 |
D/D |
(34,656) |
133,047 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2024-02-08 |
4 |
AS |
$9.18 |
$140,846 |
D/D |
(15,344) |
384,002 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2024-06-03 |
4 |
S |
$7.00 |
$125,104 |
I/I |
(17,872) |
158,502 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2023-12-08 |
4 |
AS |
$5.27 |
$105,476 |
D/D |
(20,000) |
329,271 |
0 |
% |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-09-15 |
4/A |
AS |
$22.01 |
$55,898 |
D/D |
(2,540) |
23,340 |
0 |
- |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-09-15 |
4 |
AS |
$22.01 |
$55,898 |
I/I |
(2,540) |
75,052 |
0 |
- |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2023-12-05 |
4 |
AS |
$5.00 |
$51,360 |
D/D |
(10,272) |
349,271 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2024-02-26 |
4 |
S |
$9.20 |
$47,684 |
I/I |
(5,183) |
175,936 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2024-02-20 |
4 |
S |
$8.75 |
$43,880 |
D/D |
(5,017) |
378,985 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2021-04-06 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
160,047 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2023-12-14 |
4 |
AS |
$5.55 |
$38,850 |
D/D |
(7,000) |
322,271 |
0 |
% |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-07-30 |
4 |
AS |
$19.27 |
$38,755 |
I/I |
(2,011) |
75,581 |
0 |
- |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-07-30 |
4/A |
AS |
$19.27 |
$38,755 |
D/D |
(2,011) |
25,880 |
0 |
- |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2024-05-21 |
4 |
S |
$7.81 |
$37,922 |
D/D |
(4,855) |
376,479 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2023-12-18 |
4 |
AS |
$6.07 |
$34,447 |
D/D |
(5,675) |
316,596 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2022-06-06 |
4 |
S |
$0.64 |
$28,628 |
D/D |
(44,004) |
303,916 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2017-04-18 |
4 |
S |
$11.98 |
$24,577 |
D/D |
(2,051) |
40,129 |
0 |
- |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-09-03 |
4 |
AS |
$19.25 |
$24,082 |
D/D |
(1,251) |
25,880 |
0 |
- |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-09-01 |
4 |
AS |
$18.32 |
$23,560 |
I/I |
(1,286) |
0 |
0 |
- |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2021-05-28 |
4 |
S |
$7.22 |
$22,098 |
I/I |
(3,062) |
26,750 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2024-02-20 |
4 |
S |
$8.75 |
$20,064 |
I/I |
(2,294) |
181,119 |
0 |
% |
|
ARDX |
Ardelyx Inc |
Chief Development Officer |
|
2020-09-15 |
4 |
S |
$5.51 |
$19,131 |
I/I |
(3,470) |
21,662 |
0 |
% |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-09-21 |
4 |
AS |
$22.09 |
$17,674 |
I/I |
(800) |
74,252 |
0 |
- |
|
ARDX |
Ardelyx Inc |
SVP, Drug Development |
|
2015-09-21 |
4/A |
AS |
$22.09 |
$17,674 |
D/D |
(800) |
22,540 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|